The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
J. Hobart,D. Lamping,2 Authors,A. Thompson
2001 · DOI: 10.1093/BRAIN/124.5.962
1,110 Citations
TLDR
Results indicate the MSIS-29 is a clinically useful and scientifically sound patient-based outcome measure of the impact of multiple sclerosis suitable for clinical trials and epidemiological studies.